Tyra Biosciences, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Tyra Biosciences, Inc.
CIK #0001863127
EDGAR Form CIK 2011 - 2024
10-K [0001863127]
10-Q [0001863127]
3 [0001863127]
4 [0001863127]
8-K [0001863127]
D [0001863127]
SC 13D [0001863127]
SC 13G [0001863127]
Form 13D/13G Filer Form 13D/13G Subject Filed
Biotechnology Value Fund L P TYRA Biosciences Inc [2022-03-24]
FMR LLC TYRA Biosciences Inc [2022-02-09]
Canaan Xi LP TYRA Biosciences Inc [2022-02-08]
RA Capital Management LP TYRA Biosciences Inc [2021-09-27]
Nextech VI Oncology SCSP TYRA Biosciences Inc [2021-09-27]
Alta Partners Nextgen Fund II Management LLC TYRA Biosciences Inc [2021-09-27]
Boxer Capital LLC TYRA Biosciences Inc [2021-09-24]
TCG Crossover Management LLC TYRA Biosciences Inc [2021-09-21]
Form 3/4/5 Subject 2011 - 2024
Harris Todd
Tyra Biosciences, Inc.
Fuhrman Alan
Warner Douglas J
Bensen Daniel
Kaplan Gilla
RA Capital Management LP
RA Capital Healthcare Fund LP
Shah Rajeev M.
Kolchinsky Peter
RA Capital Nexus Fund, L.P.
Subramony Siddarth
More Robert J
Simson Jake
Verjee Rehan
Kjellson Nina S
Rothenberg Stephen Michael
Moran Susan
Tada Hiroomi
MVA Investors, LLC
Lewis Joseph
Boxer Capital, LLC
Boxer Asset Management Inc.
Davis Aaron I.
Chen ISAN
Patel Piyush R.
van den Boom Esther
Hudkins Robert L.
Swanson Ronald V.
Fawaz Ali D.
Healy John Stephen
Cormorant Global Healthcare Master Fund, LP
Cormorant Private Healthcare Fund III LP
Chen Bihua
Cormorant Asset Management, LP
Canaan Partners 2020+ Co-Investment LLC
Canaan Partners XI LLC
Canaan 2020+ Co-Investment L.P. Series 7
Canaan XI L.P.
Janney Daniel
Alta Partners NextGen Fund II, L.P.
Hudson Peter A
Alta Partners NextGen Fund II Management, LLC
McCracken Melissa
Terms | Privacy | Guide
tony@aum13f.com